Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dollar General Corp. (DG) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance

Dollar General Corp.Trade
Recursion Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Dollar General Corp. vs Recursion Pharmaceuticals Inc — how do they compare? Dollar General Corp. trades at $120.1 (market cap $26.49B), while Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.81B). The key difference: Dollar General Corp. is far larger — about 14.6× Recursion Pharmaceuticals Inc's market cap, and Dollar General Corp. pays a 1.97% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

DGRXRX
Market Cap
$26.49B$1.81B
Sector
Consumer StaplesHealth
52-Week High
$156.26$6.79
52-Week Low
$95.94$2.84
Enterprise Value
$40.93B$1.33B
Dividend Yield
1.97%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Dollar General Corp.

A leading American discount retailer, Dollar General operates over 18,000 stores in 47 states, selling branded and private-label products across a wide variety of categories. In fiscal 2021, 77% of net sales came from consumables (including paper and cleaning products, packaged and perishable food, tobacco, and health and beauty items), 12% from seasonal merchandise (such as toys, greeting cards, decorations, and gardening supplies), 7% from home products (for example, kitchen supplies, small appliances, and cookware), and 4% from basic apparel. Stores average roughly 7,400 square feet, and about 75% of Dollar General locations are in towns of 20,000 or fewer people. The firm emphasizes value, with most of its items sold at everyday low prices of $5 or less.

Read more on DG

About Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.

Read more on RXRX